About the Presenter
Rakesh DIXIT, PhD, DABT
Vice President, R&D; Global Head, Translational Sciences-Biologics
Dr. Rakesh DIXIT has more than 30 years of experience in biopharmaceutical drug industry, including Merck, Johnson & Johnson and Medimmune (AstraZeneca). At his current role as the Vice President of R &D and Global Head of Safety Assessment-Translational Sciences, in Medimmune, Rakesh is responsible for providing guidance on research and development of biological products; including nonclinical toxicology/safety support for all AstraZeneca-MedImmune biologics products, including monoclonal antibodies and vaccines.